Literature DB >> 16039004

The splicing machinery is a genetic modifier of disease severity.

Malka Nissim-Rafinia1, Batsheva Kerem.   

Abstract

Disease severity correlates with the level of correctly spliced RNA transcribed from genes carrying splicing mutations and with the ratio of alternatively spliced isoforms. Hence, a role for splicing regulation as a genetic modifier has been suggested. Here we discuss recent experiments that provide direct evidence that changes in the level of splicing factors modulate the splicing pattern of disease-associated genes. Importantly, modulation of the splicing pattern led to regulation of the protein function and modification of disease severity.

Mesh:

Substances:

Year:  2005        PMID: 16039004     DOI: 10.1016/j.tig.2005.07.005

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  23 in total

1.  Heritability of alternative splicing in the human genome.

Authors:  Tony Kwan; David Benovoy; Christel Dias; Scott Gurd; David Serre; Harry Zuzan; Tyson A Clark; Anthony Schweitzer; Michelle K Staples; Hui Wang; John E Blume; Thomas J Hudson; Rob Sladek; Jacek Majewski
Journal:  Genome Res       Date:  2007-08       Impact factor: 9.043

2.  Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia.

Authors:  Matthew M Hims; El Chérif Ibrahim; Maire Leyne; James Mull; Lijuan Liu; Conxi Lazaro; Ranjit S Shetty; Sandra Gill; James F Gusella; Robin Reed; Susan A Slaugenhaupt
Journal:  J Mol Med (Berl)       Date:  2007-01-06       Impact factor: 4.599

3.  Identification of common genetic variants controlling transcript isoform variation in human whole blood.

Authors:  Xiaoling Zhang; Roby Joehanes; Brian H Chen; Tianxiao Huan; Saixia Ying; Peter J Munson; Andrew D Johnson; Daniel Levy; Christopher J O'Donnell
Journal:  Nat Genet       Date:  2015-02-16       Impact factor: 38.330

Review 4.  Alternative splicing of the neurofibromatosis type I pre-mRNA.

Authors:  Victoria A Barron; Hua Lou
Journal:  Biosci Rep       Date:  2012-04-01       Impact factor: 3.840

5.  Branch point identification and sequence requirements for intron splicing in Plasmodium falciparum.

Authors:  Xiaohong Zhang; Caitlin A Tolzmann; Martin Melcher; Brian J Haas; Malcolm J Gardner; Joseph D Smith; Jean E Feagin
Journal:  Eukaryot Cell       Date:  2011-09-16

Review 6.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Alternative splicing and nonsense-mediated decay regulate telomerase reverse transcriptase (TERT) expression during virus-induced lymphomagenesis in vivo.

Authors:  Souheila Amor; Sylvie Remy; Ginette Dambrine; Yves Le Vern; Denis Rasschaert; Sylvie Laurent
Journal:  BMC Cancer       Date:  2010-10-21       Impact factor: 4.430

Review 8.  Genetics of gene expression in CNS.

Authors:  Ashutosh K Pandey; Robert W Williams
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

9.  A targeted deleterious allele of the splicing factor SCNM1 in the mouse.

Authors:  Viive M Howell; Georgius de Haan; Sarah Bergren; Julie M Jones; Cymbeline T Culiat; Edward J Michaud; Wayne N Frankel; Miriam H Meisler
Journal:  Genetics       Date:  2008-09-14       Impact factor: 4.562

10.  RNA processing and mRNA surveillance in monogenic diabetes.

Authors:  Jonathan M Locke; Lorna W Harries
Journal:  Gene Regul Syst Bio       Date:  2008-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.